AUDITING:
Covalon Technologies Ltd is an incorporated public company. Its principal business is to research, develop, and manufacture various patent-protected medical products that heals or improves infections, tissue repair, wound care, and surgical procedures; This industry has a low level concentration, without the monopoly of any big firm (Government of Canada). Besides this, Covalon is marketing and selling its products nationally and worldwide.
The Company generates its revenues through development contracts, licensing agreements, distribution contracts, and sales of two major product categories: patented products labeled with the Company’s name, and medical products for other medical companies under development and license contracts.
The global market projects the increase of the demand for those products due to the aging population, and the profits will reach over USD 75 billion by 2026. In 2020, North America accounted for the largest share of the infection control and wound care markets (Cision, 2021)(Fortune Business insights, 2020). However, one of the biggest issues is the ability of Canadian companies to compete with other countries because of factors like cost, availability of skilled employees, and market attractiveness. Adding the reliance to the overseas suppliers which makes the supply chain vulnerable to disruptions risk. Recently, Covalon started expanding its contracts to the Middle East and Latin America where legislation encourages foreign businesses to enter their markets, especially the medical device one (Government of Canada).
The company invests in R&D and acquires new technologies to stay competitive. Covalon Technologies Ltd. is” ISO 13485: 2016[1], MDSAP[2] and FDA QSR[3] certified, and follows strict GMP processes to support product development from concept to scalable market release” (Covalon, 20210. The federal government funds health-related research programs and offers “The Canadian Scientific Research and Experimental Development (SR&ED) tax incentive program” to encourage Canadian businesses to conduct R&D in Canada by providing claimants with cash refunds and/or tax credits for their expenditures on R&D (Government of Canada).
The Company is listed on the TSX, having the symbol COV. The Company also trades on the OTCQX Best Market, having the symbol of CVALF. The address of the Company’s corporate office and principal place of business is 1660 Tech Avenue, Unit 5, Mississauga, Ontario, Canada.
QUESTION:
Perform a fraud risk assessment and give 5 key fraud risks for this company along with overall conclusion on fraud risk level.
Please do not send any link.
Answers: 3
Another question on Business
Business, 22.06.2019 15:20
Capital financial corporation will lend 90 percent against account balances that have averaged 30 days or less; 80 percent for account balances between 31 and 40 days; and 70 percent for account balances between 41 and 45 days. customers that take over 45 days to pay their bills are not considered acceptable accounts for a loan. the current prime rate is 16.50 percent, and capital charges 3.50 percent over prime to charming as its annual loan rate. a. determine the maximum loan for which charming paper company could qualify.
Answers: 1
Business, 23.06.2019 02:50
Kandon enterprises, inc., has two operating divisions; one manufactures machinery and the other breeds and sells horses. both divisions are considered separate components as defined by generally accepted accounting principles. the horse division has been unprofitable, and on november 15, 2018, kandon adopted a formal plan to sell the division. the sale was completed on april 30, 2019. at december 31, 2018, the component was considered held for sale. on december 31, 2018, the company’s fiscal year-end, the book value of the assets of the horse division was $415,000. on that date, the fair value of the assets, less costs to sell, was $350,000. the before-tax loss from operations of the division for the year was $290,000. the company’s effective tax rate is 40%. the after-tax income from continuing operations for 2018 was $550,000. required: 1. prepare a partial income statement for 2018 beginning with income from continuing operations. ignore eps disclosures. 2. prepare a partial income statement for 2018 beginning with income from continuing operations. assuming that the estimated net fair value of the horse division’s assets was $700,000, instead of $350,000. ignore eps disclosures.
Answers: 2
Business, 23.06.2019 04:50
According to fiedler, in situations that are very unfavorable for the leader, it would be wise to choose someone who: a. is task oriented. b. is likely to engage in behaviors that are classified as consideration behaviors. c. has a low lpc score. d. has a high lpc score.
Answers: 1
Business, 23.06.2019 07:00
Which (if any) of the following scenarios is the result of a natural monopoly? instructions: you may select more than one answer. a. patent holders of genetically modified seeds are permitted to sue farmers who save seeds from one planting season to the next. b. doctors in the united states are prohibited from practicing without a medical license. c. there is one train operator with service from baltimore to philadelphia. d. coal is used as the primary energy in a country with abundant coal deposits.
Answers: 1
You know the right answer?
AUDITING:
Covalon Technologies Ltd is an incorporated public company. Its principal business is to...
Questions
Computers and Technology, 16.12.2019 21:31
